Please contact Suzanne Atkins or RDS Grants & Tenders if you intend to apply to this grant opportunity.

 

Opening date:	14 December 2020
Closing date for minimum data: Application closing date and time:	5pm ACT local time on 24 February 2021 5pm ACT local time on 10 March 2021
Administering entity:	National Health and Medical Research Council
Total Amount Available (AUD):	$25,000,000.00
Estimated Grant Value (AUD):	Up to $4,000,000.00
Guidelines and Documents:	GO4535

Objective: To support Australian medical research and medical innovation projects in one of the following streams:

• Stream 1: utilise existing evidence to develop or improve approaches for the early diagnosis of ovarian cancer, cancers of the pancreas, liver cancer or lung cancer that have a clinically feasible pathway to implementation
• Stream 2: enable approaches for the early diagnosis of cancers with unknown primary site that have a clinically feasible pathway to implementation.

Intended outcome: To improve the health and wellbeing of Australians by supporting research that improves the five-year relative survival rate for ovarian cancer, cancers of the pancreas, liver cancer, lung cancer and cancers with unknown primary site by enabling early diagnosis.

How to apply: NHMRC’s online granting system (Sapphire)